These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter? Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239 [TBL] [Abstract][Full Text] [Related]
4. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux. Chi A; Gupta A; Snodgrass W J Urol; 2008 May; 179(5):1966-9. PubMed ID: 18355849 [TBL] [Abstract][Full Text] [Related]
5. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer. Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756 [TBL] [Abstract][Full Text] [Related]
6. Febrile urinary tract infections in children with an early negative voiding cystourethrogram after treatment of vesicoureteral reflux with dextranomer/hyaluronic acid. Sedberry-Ross S; Rice DC; Pohl HG; Belman AB; Majd M; Rushton HG J Urol; 2008 Oct; 180(4 Suppl):1605-9; discussion 1610. PubMed ID: 18710762 [TBL] [Abstract][Full Text] [Related]
7. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results. Friedmacher F; Colhoun E; Puri P J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405 [TBL] [Abstract][Full Text] [Related]
8. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. Stenberg A; Larsson E; Läckgren G J Urol; 2003 Mar; 169(3):1109-13. PubMed ID: 12576864 [TBL] [Abstract][Full Text] [Related]
9. Salvage extravesical ureteral reimplantation after failed endoscopic surgery for vesicoureteral reflux. Elmore JM; Kirsch AJ; Perez-Brayfield MR; Scherz HC; Koyle MA J Urol; 2006 Sep; 176(3):1158-60. PubMed ID: 16890716 [TBL] [Abstract][Full Text] [Related]
10. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter? Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422 [TBL] [Abstract][Full Text] [Related]
11. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems. Hunziker M; Mohanan N; Puri P J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268 [TBL] [Abstract][Full Text] [Related]
12. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon. Yu RN; Roth DR Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825 [TBL] [Abstract][Full Text] [Related]
13. Outcome analysis of mini-ureteroneocystostomy versus dextranomer/hyaluronic acid copolymer injection for unilateral vesicoureteral reflux. Ashley R; Vandersteen D J Urol; 2008 Oct; 180(4 Suppl):1611-3; discussion 1614. PubMed ID: 18710741 [TBL] [Abstract][Full Text] [Related]
14. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review. Chung KLY; Sihoe J; Liu K; Chao N; Hung J; Liu C; Yam F; Leung Y; Tam P; Lee KH; Leung M J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690 [TBL] [Abstract][Full Text] [Related]
15. Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux. Ben-Meir D; Morgenstern S; Sivan B; Efrat R; Livne PM J Urol; 2012 Jul; 188(1):258-61. PubMed ID: 22595062 [TBL] [Abstract][Full Text] [Related]
16. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux. Puri P; Kutasy B; Colhoun E; Hunziker M J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657 [TBL] [Abstract][Full Text] [Related]
17. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon. Hsieh MH; Madden-Fuentes RJ; Lindsay NE; Roth DR Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980 [TBL] [Abstract][Full Text] [Related]
18. Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction. Läckgren G; Sköldenberg E; Stenberg A J Urol; 2007 Mar; 177(3):1124-8; discussion 1128-9. PubMed ID: 17296428 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of concomitant autologous blood and dextranomer/hyaluronic acid copolymer injection to correct vesicoureteral reflux. Kajbafzadeh AM; Tourchi A J Urol; 2012 Sep; 188(3):948-52. PubMed ID: 22819104 [TBL] [Abstract][Full Text] [Related]
20. Appearance of dextranomer/hyaluronic Acid copolymer implants on computerized tomography after endoscopic treatment of vesicoureteral reflux in children. Cerwinka WH; Qian J; Easley KA; Scherz HC; Kirsch AJ J Urol; 2009 Mar; 181(3):1324-8; discussion 1329. PubMed ID: 19157427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]